Using lavender aromatherapy to reduce anxiety before ultrasound procedures
The Effects of Aromatherapy on Anxiety Prior to Ultrasound Guided Musculoskeletal Procedures: A Randomized Controlled Trial
NA · University of Miami · NCT05660486
This study is testing if breathing in lavender scent can help adults feel less anxious before having ultrasound procedures.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 48 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | University of Miami (other) |
| Locations | 1 site (Miami, Florida) |
| Trial ID | NCT05660486 on ClinicalTrials.gov |
What this trial studies
This study evaluates the impact of lavender essential oil aromatherapy on anxiety levels in adults aged 18-85 who are about to undergo ultrasound guided musculoskeletal procedures. Participants will be randomly assigned to receive either lavender aromatherapy or a placebo before their procedure. The primary focus is to determine if the aromatherapy can effectively reduce pre-procedure anxiety, potentially improving patient comfort and outcomes during the intervention.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-85 who are scheduled for ultrasound guided musculoskeletal procedures and are proficient in English.
Not a fit: Patients currently on benzodiazepine therapy, those with allergies to lavender, or individuals with significant respiratory issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a non-invasive method to alleviate anxiety in patients undergoing medical procedures.
How similar studies have performed: While the use of aromatherapy for anxiety is a growing area of interest, this specific application in the context of ultrasound guided procedures is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: Adults ages 18-85. Those undergoing ultrasound guided musculoskeletal procedures including joint, tendon, bursa, or periarticular structure injection/ aspiration. Proficient with English. Exclusion criteria: Patients currently on benzodiazepine anxiolytic therapy Those with significantly impaired sense of smell Allergy/aversion to lavender essential oils Patients with asthma Patients with history of migraines Patients with any other condition that, in the opinion of the investigator, would compromise the well-being of the patient or prevent the patient from meeting or performing study requirements Adults unable to consent Individuals who are not yet adults Pregnant women Prisoners
Where this trial is running
Miami, Florida
- University of Miami Hospital — Miami, Florida, United States (RECRUITING)
Study contacts
- Principal investigator: Tricia Prince, DO — University of Miami
- Study coordinator: Jonathan Presley, MD
- Email: jrp184@med.miami.edu
- Phone: 305 585 9600
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Anxiety State